[Pharmacogenomics of the immunosuppressive agents].
Taniguchi
Atsuo
A
Institute of Rheumatology, Tokyo Women's Medical University.
Urano
Wako
W
Tanaka
Eiichi
E
Kitamura
Yutaka
Y
Saito
Masayuki
M
Akama
Hideto
H
Yamanak
Hishashi
H
Saito
Terunobu
T
Kamatani
Naoyuki
N
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000235:genetics; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D008875:Middle Aged; D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000235:genetics*
D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D000587:Oxidoreductases Acting on CH-NH Group Donors; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D008727:Methotrexate